Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNE1 | P24864 | 19/20 | 0.52 |
| ▸ | CDK2 | P24941 | 19/20 | 0.52 |
| ▸ | CCND1 | P24385 | 12/20 | 0.52 |
| ▸ | CDK6 | Q00534 | 12/20 | 0.52 |
| ▸ | CDK1 | P06493 | 11/20 | 0.52 |
| ▸ | CCNB1 | P14635 | 11/20 | 0.52 |
| ▸ | CDK4 | P11802 | 10/20 | 0.52 |
| ▸ | CCND3 | P30281 | 10/20 | 0.52 |
| ▸ | CCNT1 | O60563 | 5/20 | 0.52 |
| ▸ | CDK7 | P50613 | 5/20 | 0.52 |
| ▸ | CDK9 | P50750 | 5/20 | 0.52 |
| ▸ | CCNH | P51946 | 5/20 | 0.52 |
| ▸ | MNAT1 | P51948 | 5/20 | 0.52 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26941879 | 0.91 | CCNE1 (0.52) | CCNE1CDK2CCND1CDK6CDK1 | |
| SCHEMBL26942675 | 0.89 | CDK2 (0.58) | CCNE1CDK2CCND1CDK6CDK1 | |
| SCHEMBL29762995 | 0.89 | CDK2 (0.58) | CCNE1CDK2CCND1CDK6CDK1 | |
| SCHEMBL26918943 | 0.89 | CDK2 (0.58) | CCNE1CDK2CCND1CDK6CDK1 | |
| SCHEMBL26918947 | 0.89 | CDK2 (0.58) | CCNE1CDK2CCND1CDK6CDK1 | |
| SCHEMBL26943438 | 0.88 | CCNE1 (0.57) | CCNE1CDK2CCND1CDK6CDK1 | |
| SCHEMBL26943179 | 0.86 | CCNE1 (0.49) | CCNE1CDK2CCND1CDK6CDK1 | |
| SCHEMBL26942927 | 0.86 | CDK2 (0.48) | CCNE1CDK2CCND1CDK6CDK1 | |
| SCHEMBL26942911 | 0.84 | CDK2 (0.58) | CCNE1CDK2CCND1CDK6CDK1 | |
| SCHEMBL26943283 | 0.82 | CDK2 (0.57) | CCNE1CDK2CCND1CDK6CDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4289835-A1 | CDK INHIBITOR | Shanghai Qilu Pharmaceutical Research and Development Centre Ltd. (CN) | 2023-12-13 | — | — | EP | disclosed |